Illumina Inc
NASDAQ:ILMN

Watchlist Manager
Illumina Inc Logo
Illumina Inc
NASDAQ:ILMN
Watchlist
Price: 141.09 USD 0.84% Market Closed
Market Cap: 22.4B USD
Have any thoughts about
Illumina Inc?
Write Note

Intrinsic Value

The intrinsic value of one ILMN stock under the Base Case scenario is 141.3 USD. Compared to the current market price of 141.09 USD, Illumina Inc is Fairly Valued.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ILMN Intrinsic Value
141.3 USD
Fairly Valued
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Illumina Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for ILMN cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about ILMN?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Illumina Inc

Provide an overview of the primary business activities
of Illumina Inc.

What unique competitive advantages
does Illumina Inc hold over its rivals?

What risks and challenges
does Illumina Inc face in the near future?

Has there been any significant insider trading activity
in Illumina Inc recently?

Summarize the latest earnings call
of Illumina Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Illumina Inc.

Provide P/S
for Illumina Inc.

Provide P/E
for Illumina Inc.

Provide P/OCF
for Illumina Inc.

Provide P/FCFE
for Illumina Inc.

Provide P/B
for Illumina Inc.

Provide EV/S
for Illumina Inc.

Provide EV/GP
for Illumina Inc.

Provide EV/EBITDA
for Illumina Inc.

Provide EV/EBIT
for Illumina Inc.

Provide EV/OCF
for Illumina Inc.

Provide EV/FCFF
for Illumina Inc.

Provide EV/IC
for Illumina Inc.

Show me price targets
for Illumina Inc made by professional analysts.

What are the Revenue projections
for Illumina Inc?

How accurate were the past Revenue estimates
for Illumina Inc?

What are the Net Income projections
for Illumina Inc?

How accurate were the past Net Income estimates
for Illumina Inc?

What are the EPS projections
for Illumina Inc?

How accurate were the past EPS estimates
for Illumina Inc?

What are the EBIT projections
for Illumina Inc?

How accurate were the past EBIT estimates
for Illumina Inc?

Compare the revenue forecasts
for Illumina Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Illumina Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Illumina Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Illumina Inc compared to its peers.

Compare the P/E ratios
of Illumina Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Illumina Inc with its peers.

Analyze the financial leverage
of Illumina Inc compared to its main competitors.

Show all profitability ratios
for Illumina Inc.

Provide ROE
for Illumina Inc.

Provide ROA
for Illumina Inc.

Provide ROIC
for Illumina Inc.

Provide ROCE
for Illumina Inc.

Provide Gross Margin
for Illumina Inc.

Provide Operating Margin
for Illumina Inc.

Provide Net Margin
for Illumina Inc.

Provide FCF Margin
for Illumina Inc.

Show all solvency ratios
for Illumina Inc.

Provide D/E Ratio
for Illumina Inc.

Provide D/A Ratio
for Illumina Inc.

Provide Interest Coverage Ratio
for Illumina Inc.

Provide Altman Z-Score Ratio
for Illumina Inc.

Provide Quick Ratio
for Illumina Inc.

Provide Current Ratio
for Illumina Inc.

Provide Cash Ratio
for Illumina Inc.

What is the historical Revenue growth
over the last 5 years for Illumina Inc?

What is the historical Net Income growth
over the last 5 years for Illumina Inc?

What is the current Free Cash Flow
of Illumina Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Illumina Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Illumina Inc

Current Assets 2.4B
Cash & Short-Term Investments 939m
Receivables 715m
Other Current Assets 719m
Non-Current Assets 3.6B
Long-Term Investments 218m
PP&E 1.3B
Intangibles 1.4B
Other Non-Current Assets 720m
Current Liabilities 975m
Accounts Payable 191m
Accrued Liabilities 422m
Other Current Liabilities 362m
Non-Current Liabilities 2.9B
Long-Term Debt 2B
Other Non-Current Liabilities 926m
Efficiency

Earnings Waterfall
Illumina Inc

Revenue
4.4B USD
Cost of Revenue
-1.6B USD
Gross Profit
2.8B USD
Operating Expenses
-2.5B USD
Operating Income
344m USD
Other Expenses
-1.9B USD
Net Income
-1.6B USD

Free Cash Flow Analysis
Illumina Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ILMN Profitability Score
Profitability Due Diligence

Illumina Inc's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
ROIC is Increasing
Positive Revenue Growth Forecast
37/100
Profitability
Score

Illumina Inc's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

ILMN Solvency Score
Solvency Due Diligence

Illumina Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
60/100
Solvency
Score

Illumina Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ILMN Price Targets Summary
Illumina Inc

Wall Street analysts forecast ILMN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ILMN is 167.19 USD with a low forecast of 121.2 USD and a high forecast of 266.7 USD.

Lowest
Price Target
121.2 USD
14% Downside
Average
Price Target
167.19 USD
19% Upside
Highest
Price Target
266.7 USD
89% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ILMN?

Click here to dive deeper.

Dividends

Illumina Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ILMN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ILMN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

ILMN News

Other Videos

Profile

Illumina Inc Logo
Illumina Inc

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

22.4B USD

Dividend Yield

0%

Description

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 9,800 full-time employees. The company went IPO on 2000-06-28. The firm operates through two segments: Core Illumina and GRAIL. Core Illumina products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. GRAIL is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Customers use its platforms to perform whole genome, de novo, exome and ribonucleic acid (RNA) sequencing, and targeted resequencing of specific gene regions and genes. The firm's BeadArray technology produces arrays that can perform many assays simultaneously. Customers use its array-based genotyping consumables for a range of analyses, including diverse species, disease-related mutations, and genetic characteristics associated with cancer.

Contact

CALIFORNIA
San Diego
5200 Illumina Way
+18582024500.0
www.illumina.com

IPO

2000-06-28 00:00:00

Employees

9 800

Officers

CEO & Director
Mr. Jacob Thaysen Ph.D.
Chief Information Officer
Ms. Carissa L. Rollins
Advisor
Mr. Charles E. Dadswell Esq.
President
Stephanie Campos
Chief of Global Operations
Mr. Kevin Carl Pegels
VP & Chief Accounting Officer
Mr. Scott Ericksen
Show More
Chief Technology Officer
Dr. Steven Barnard Ph.D.
Vice President of Investor Relations
Ms. Sallilyn Schwartz
Interim General Counsel & Secretary
Mr. Scott Davies
Chief Strategy & Corporate Development Officer and CEO Chief of Staff
Mr. Jakob Wedel
Show Less

See Also

Discover More
What is the Intrinsic Value of one ILMN stock?

The intrinsic value of one ILMN stock under the Base Case scenario is 141.3 USD.

Is ILMN stock undervalued or overvalued?

Compared to the current market price of 141.09 USD, Illumina Inc is Fairly Valued.

Back to Top